Josep‐María Ribera

Research interests

Publications

• Management of ALL in adults: 2024 ELN recommendations from a European expert panel

  Blood · 2024 · https://doi.org/10.1182/blood.2023023568

• Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panel

  Blood · 2024 · https://doi.org/10.1182/blood.2023020794

• Hematopoietic stem cell transplantation for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission: a position statement of the European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL) and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

  Bone Marrow Transplantation · 2018 · https://doi.org/10.1038/s41409-018-0373-4

• Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia

  New England Journal of Medicine · 2017 · https://doi.org/10.1056/nejmoa1609783

• Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome–positive ALL

  Blood · 2016 · https://doi.org/10.1182/blood-2016-02-700153

• International reference analysis of outcomes in adults with B-precursor Ph-negative relapsed/refractory acute lymphoblastic leukemia

  Haematologica · 2016 · https://doi.org/10.3324/haematol.2016.144311

• Treatment of High-Risk Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia in Adolescents and Adults According to Early Cytologic Response and Minimal Residual Disease After Consolidation Assessed by Flow Cytometry: Final Results of the PETHEMA ALL-AR-03 Trial

  Journal of Clinical Oncology · 2014 · https://doi.org/10.1200/jco.2013.52.2425

• Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients

  Blood · 2013 · https://doi.org/10.1182/blood-2013-04-498964

• Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens

  Blood · 2010 · https://doi.org/10.1182/blood-2010-04-277434

• Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome

  Blood · 2010 · https://doi.org/10.1182/blood-2010-01-266007

• Influence of Pre- and Post-Transplantation Responses on Outcome of Patients With Multiple Myeloma: Sequential Improvement of Response and Achievement of Complete Response Are Associated With Longer Survival

  Journal of Clinical Oncology · 2008 · https://doi.org/10.1200/jco.2008.17.9721

• Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes.

  PubMed · 2005

• Minimal residual disease monitoring in multiple myeloma: a comparison between allelic-specific oligonucleotide real-time quantitative polymerase chain reaction and flow cytometry.

  PubMed · 2005

• Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups.

  PubMed · 2000

• Mantle cell lymphoma

  Cancer · 1998 · https://doi.org/10.1002/(sici)1097-0142(19980201)82:3<567::aid-cncr20>3.0.co;2-z

Current projects

No projects listed.